Sygnature Discovery is a leading United Kingdom-based provider of integrated drug discovery services. Key areas of expertise include medicinal and synthetic chemistry, computational chemistry and bioscience (in vitro biology and screening). The company was founded in 2004 in BioCity (www.biocity.co.uk) and occupies modern, purpose-built laboratories and offices near to the centre of Nottingham. Our clients are located in the USA and Europe, and range from small biotechnology companies to medium-sized pharmaceutical companies.
Sygnatures team of over 50 industry-experienced medicinal chemists and bioscientists add considerable value to clients drug discovery activities by undertaking complete drug discovery programmes and key elements of the drug discovery process, such as hit finding, hit-to-lead and lead optimisation. Sygnatures scientists provide considerable intellectual input into clients projects; thereby generating novel intellectual property. Pharmaceutical candidates discovered at Sygnature for clients are currently undergoing clinical trials in a variety of diseases with unmet medical need.
Phone: +44 (0)115 941 5401
Website: Sygnature Discovery